Soft tissue sarcomas

Cancer Treatment and Research

Volumn 162, Issue , 2014, Pages 203-223

  Spiguel, Andre ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Clinical features; Diagnosis; Sarcoma; Staging; Surveillance; Treatment

Indexed keywords

EPIRUBICIN; FLUORODEOXYGLUCOSE F 18; IFOSFAMIDE; IMATINIB; VASCULOTROPIN INHIBITOR;

ALVEOLAR SOFT PART SARCOMA; ANGIOSARCOMA; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CLEAR CELL SARCOMA; COMPUTER ASSISTED TOMOGRAPHY; DERMATOFIBROSARCOMA PROTUBERANS; DISEASE SPECIFIC SURVIVAL; EPITHELIOID SARCOMA; FIBROSARCOMA; GENETIC DISORDER; HIGH GRADE PLEOMORPHIC UNDIFFERENTIATED SARCOMA; HUMAN; LEIOMYOSARCOMA; LIMB SALVAGE; LIPOSARCOMA; LUNG METASTASIS; LYMPHEDEMA; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MYXOFIBROSARCOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SURVIVAL RATE; SYNOVIAL SARCOMA; TUMOR BIOPSY; TUMOR RECURRENCE; BIOPSY TECHNIQUE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DISEASE FREE SURVIVAL; DISEASE SURVEILLANCE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; RADIATION DOSE; RISK FACTOR; TUMOR VOLUME;

BIOPSY; FIBROMA; FIBROSARCOMA; HEMANGIOSARCOMA; HUMANS; LEIOMYOSARCOMA; LIPOSARCOMA; NERVE SHEATH NEOPLASMS; RHABDOMYOSARCOMA; RISK FACTORS; SARCOMA; SARCOMA, CLEAR CELL; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS;

EID: 84958530840     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-319-07323-1_10     Document Type: Article

References (49)

1. Weitz J, Antonescu CR, Brennan MF (2003) Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol 21(14):2719-2725
2. Fletcher CDM (2013) World Health Organization., and International Agency for Research on Cancer., WHO classification of tumours of soft tissue and bone, 4th edn. World Health Organization classification of tumours. IARC Press, Lyon, p 468
3. DeVita VT, Hellman S, Rosenberg SA (2005) Cancer, principles and practice of oncology, 7th edn. Philadelphia, Lippincott Williams & Wilkins, lxxv, p 2898
4. Clark MA et al (2005) Soft-Tissue sarcomas in adults. N Engl J Med 353(7):701-711
5. Gladdy RA et al (2010) Do radiation-Associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?. J Clin Oncol 28(12):2064-2069
6. Stewart FW, Treves N (1948) Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1(1):64-81
7. Henze J, Bauer S (2013) Liposarcomas. Hematol Oncol Clin North Am 27(5):939-955
8. Fiore M et al (2007) Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution. Cancer 109(12):2522-2531
9. Folpe AL (2014) Fibrosarcoma: a review and update. Histopathology 64(1):12-25
10. Sanfilippo R et al (2011) Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol 18(3):720-725
11. McArthur GA et al (2005) Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 23(4):866-873
12. Mendenhall WM, Zlotecki RA, Scarborough MT (2004) Dermatofibrosarcoma protuberans. Cancer 101(11):2503-2508
13. Gladdy RA et al (2013) Predictors of survival and recurrence in primary leiomyosarcoma. Ann Surg Oncol 20(6):1851-1857
14. Mark RJ et al (1996) Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 77(11):2400-2406
15. Ferner RE, Gutmann DH (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62(5):1573-1577
16. Stacchiotti S et al (2011) Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. Ann Oncol 22(7):1682-1690
17. Guzzetta AA et al (2012) Epithelioid sarcoma: one institution's experience with a rare sarcoma. J Surg Res 177(1):116-122
18. Dim DC, Cooley LD, Miranda RN (2007) Clear cell sarcoma of tendons and aponeuroses: a review. Arch Pathol Lab Med 131(1):152-156
19. Conrad EU 3rd, et al (2004) Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-Tissue sarcomas. J Bone Joint Surg Am 86-A Suppl 2:98-104
20. Evilevitch V et al (2008) Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-Tissue sarcomas. Clin Cancer Res 14(3):715-720
21. Al-Ibraheem A et al (2013) (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma. Cancer 119(6):1227-1234
22. Simon MA (1982) Biopsy of musculoskeletal tumors. J Bone Joint Surg Am 64(8):1253-1257
23. Mankin HJ, Mankin CJ, Simon MA (1996) The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am 78(5):656-663
24. Skrzynski MC et al (1996) Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors. J Bone Joint Surg Am 78(5):644-649
25. Adams SC et al (2010) Office-based core needle biopsy of bone and soft tissue malignancies: an accurate alternative to open biopsy with infrequent complications. Clin Orthop Relat Res 468(10):2774-2780
26. Pohlig F et al (2012) Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: a retrospective study. Eur J Med Res 17:29
27. Kasraeian S et al (2010) A comparison of fine-needle aspiration, core biopsy, and surgical biopsy in the diagnosis of extremity soft tissue masses. Clin Orthop Relat Res 468(11):2992-3002
28. Edge SB (2010) American Joint Committee on Cancer., and American Cancer Society., AJCC cancer staging handbook : from the AJCC cancer staging manual, 7th edn. Springer, New York, xix, p 718
29. Nystrom LM et al (2013) Multidisciplinary management of soft tissue sarcoma. ScientificWorldJournal 2013:852462
30. Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106-120
31. Rosenberg SA et al (1982) The treatment of soft-Tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196(3):305-315
32. Bickels J et al (2002) Sciatic nerve resection: is that truly an indication for amputation?. Clin Orthop Relat Res 399:201-204
33. Fabrizio PL, Stafford SL, Pritchard DJ (2000) Extremity soft-Tissue sarcomas selectively treated with surgery alone. Int J Radiat Oncol Biol Phys 48(1):227-232
34. Baldini EH et al (1999) Long-Term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol 17(10):3252-3259
35. Yang JC et al (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16(1):197-203
36. Mendenhall WM et al (2009) The management of adult soft tissue sarcomas. Am J Clin Oncol 32(4):436-442
37. Dagan R et al (2012) The significance of a marginal excision after preoperative radiation therapy for soft tissue sarcoma of the extremity. Cancer 118(12):3199-3207
38. O'sullivan B et al (2002) Preoperative versus postoperative radiotherapy in soft-Tissue sarcoma of the limbs: a randomised trial. Lancet 359(9325):2235-2241
39. Al-Absi E et al (2010) A systematic review and meta-Analysis of oncologic outcomes of preversus postoperative radiation in localized resectable soft-Tissue sarcoma. Ann Surg Oncol 17(5):1367-1374
40. Davis AM et al (2002) Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol 20(22):4472-4477
41. Holt GE et al (2005) Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-Tissue sarcomas. A comparison of high-dose and low-dose radiotherapy. J Bone Joint Surg Am 87(2):315-319
42. Tepper JE, Suit HD (1985) Radiation therapy alone for sarcoma of soft tissue. Cancer 56(3):475-479
43. Crowther DA (1997) Adjuvant chemotherapy for localised resectable soft-Tissue sarcoma of adults: meta-Analysis of individual data. Sarcoma Meta-Analysis Collaboration. Lancet 350(9092):1647-1654
44. Frustaci S et al (2001) Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 19(5):1238-1247
45. Frustaci S et al (2003) Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology 65(Suppl 2):80-84
46. Pisters PW et al (1996) Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14(5):1679-1689
47. Kim S et al (2011) Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes. Ann Thorac Surg 92(5):1780-1786 (discussion 1786-1787
48. Whooley BP et al (2000) Primary extremity sarcoma: what is the appropriate follow-up?. Ann Surg Oncol 7(1):9-14
49. Miller B.J. et al. CT scans for pulmonary surveillance may be overused in lower-grade sarcoma Iowa Orthop J 2012 32 28-34.